Explore the latest in hepatobiliary cancer, including advances in understanding the epidemiology, diagnosis, management, and prevention of the disease.
This single-arm, 2-stage, phase 2 clinical trial assesses the safety and efficacy of intravenous gemcitabine plus nanoparticle albumin-bound–paclitaxel for treatment of adults with advanced cholangiocarcinoma.
This pooled analysis of the Nurses’ Health Study and the Health Professionals Follow-up Study examines the association between long-term use of aspirin and the development of hepatocellular carcinoma in adult men and women.
This case report describes metastatic calcinosis cutis associated with selective FGFR inhibitor therapy.
This multicenter study investigates the risk factors, patterns, and outcomes of late recurrence after curative liver resection for hepatocellular carcinoma.
This cohort study examines the association of preoperative antiviral treatment with the incidences of microvascular invasion and posthepatectomy early tumor recurrence in adult patients with hepatitis B virus–related hepatocellular carcinoma.
This cohort study of patients in China investigates whether sustained response duration of 6 months or more following treatment with conventional transarterial chemoembolization (cTACE) is a reliable surrogate end point for overall survival in patients with intermediate hepatocellular carcinoma (HCC).
This cohort study uses data from the Korean National Health Insurance Service database to compare the risk of hepatocellular cancer associated with entecavir vs tenofovir disoproxil fumarate in patients receiving long-term treatment for chronic hepatitis B infection.
This JAMA Patient Page describes the symptoms, diagnosis, and treatment of gallbladder cancer.
This analysis of population-level data examines evidence of the association between body mass index and development of hepatocellular carcinoma among men and women with chronic hepatitis B virus infection.
This randomized clinical trial evaluates the efficacy and safety of transarterial chemoembolization plus external beam radiotherapy compared with sorafenib in patients with hepatocellular carcinoma and macroscopic vascular invasion.
This data analysis of the Global Burden of Disease 2015 study on primary liver cancer reports incidence, mortality, and disability-adjusted life-years for 195 countries or territories from 1990 to 2015, and presents global, regional, and national estimates on the burden of liver cancer.
This study assesses the prognostic influence of remnant liver ischemia after resection of colorectal liver metastases and identifies correlates of greater extent of remnant liver ischemia.
This study of California Cancer Registry records assesses the prognostic determinants of overall survival among patients undergoing liver resection for intrahepatic cholangiocarcinoma and develops a prognostic score for this purpose.
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: